Robert W. Baird initiated coverage on Agenus with a new price target

6/6/23 10:22:50 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Robert W. Baird initiated coverage of Agenus with a rating of Outperform and set a new price target of $8.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AGEN

Date	Price Target	Rating	Analyst
6/4/2025	$25.00	Neutral → Buy	H.C. Wainwright
7/19/2024	$35.00 → $8.00	Outperform → Neutral	Robert W. Baird
7/18/2024		Outperform → Mkt Perform	William Blair
7/18/2024	$9.00	Buy → Neutral	H.C. Wainwright
6/6/2023	$8.00	Outperform	Robert W. Baird
6/6/2023	$60.00 → $80.00	Outperform	Robert W. Baird
2/28/2023	$8.00	Buy	H.C. Wainwright
9/28/2022	$5.00	Outperform	SMBC Nikko